EdiShorts

UPSC Prelims 2021 GS Paper 1 Q65 · Science & Technology

Year2021
PaperGS Paper 1
QuestionQ65
SubjectScience & Technology

With reference to recent developments regarding 'Recombinant Vector Vaccines', consider the following statements:
1. Genetic engineering is applied in the development of these vaccines.
2. Bacteria and viruses are used as vectors.
Which of the statements given above is/are correct?

  1. a1 only
  2. b2 only
  3. cBoth 1 and 2
  4. dNeither 1 nor 2
Show answer & explanationHide answer
Correct answer(c) Both 1 and 2

Recombinant vector vaccines use genetic engineering and bacteria or viruses as carriers.

Statement-by-statement analysis

✓ Statement 1
  • A gene for a pathogen's antigen is inserted into a carrier organism by recombinant DNA technology.
✓ Statement 2
  • Harmless viruses (such as adenoviruses) and bacteria (such as attenuated Salmonella) serve as vectors.

Concept to know

  • Types of vaccines: live attenuated, inactivated, subunit, toxoid, viral vector, and nucleic acid (DNA and mRNA).
  • Examples of vector vaccines: Covishield, Sputnik V, Ebola vaccine Ervebo, and Johnson and Johnson's COVID-19 vaccine.
  • Vector vaccines trigger both antibody and T cell responses.
  • Pre-existing immunity to the vector can reduce effectiveness.
  • Genetic engineering involves cutting and joining DNA using restriction enzymes and ligase.

Related facts for revision

  • Recombinant hepatitis B vaccine was among the first genetically engineered vaccines.
  • mRNA vaccines (Pfizer-BioNTech, Moderna) use lipid nanoparticles.
  • India's first DNA vaccine, ZyCoV-D, was approved in 2021.
  • Intranasal vaccine iNCOVACC by Bharat Biotech is a vector-based nasal vaccine.
How UPSC tests this

Vaccine technologies behind Covid vaccines.

Trap: Thinking vectors can only be viruses.

Read more: NCERT Class 12, Biology (Biotechnology: Principles and Processes)

More Science & Technology PYQs

All Science & Technology questions →

Answer from the official UPSC answer key. Explanation by the EdiShorts editorial team.